"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. The meds you need, reliable and hassle free! Top products of top brands.The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe! |
| (NYE-moE-dih-peen) |
Nimotop, Nimotop I.V. |
| Class: Calcium channel blocker |
Action Inhibits movement of calcium ions across cell membrane in systemic and coronary vascular smooth muscle and myocardium. Has greater effect on cerebral arteries than on other arteries.
Indications Improvement of neurologic deficits caused by vasospasm after subarachnoid hemorrhage from ruptured congenital intracranial aneurysms. unlabeled use(s): Treatment of common and classic migraine and chronic cluster headache.
Contraindications Standard considerations.
Subarachnoid Hemorrhage
ADULTS: PO/Nasogastric 60 mg q 4 hr for 21 consecutive days. Initiate therapy within 96 hr of subarachnoid hemorrhage.
Headaches
ADULTS: PO 30 mg tid.
Beta-blockers: May cause increased adverse effects because of myocardial contractility or atrioventricular (AV) conduction depression. Fentanyl: May cause severe hypotension or increased fluid requirements. Other hypertensive agents: May have additive effects.
Lab Test Interferences None well documented.
CV: Peripheral edema; hypotension; hypertension; bradycardia; CHF; tachycardia; abnormal ECG. CNS: Rebound vasospasm; headache; dizziness; psychiatric disturbances. DERM: Rash; acne. GI: Nausea; diarrhea; abdominal discomfort; cramps; dyspepsia; GI hemorrhage. HEPA: Hepatitis; hepatotoxicity; elevated LDH, alkaline phosphatase and ALT levels. HEMA: Disseminated intravascular coagulation; thrombocytopenia; deep vein thrombosis. RESP: Shortness of breath; wheezing. OTHER: Flushing; muscle cramps, pain, and inflammation.
Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Antiplatelet effects: Calcium channel blockers may inhibit platelet function. Hepatic impairment: Use drug with caution in patients with impaired hepatic function or reduced hepatic blood flow.
| PATIENT CARE CONSIDERATIONS |
|
|
||||
Popularity: 1% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply